§ Ms HodgeTo ask the Secretary of State for Health what research his Department has(a) commissioned and (b) evaluated on adverse drug reaction to the anti-malarial drug Lariam (Mefloquine); and if he will indicate the number and type of reactions reported. [31322]
§ Mr. MaloneNone.
The Medicines Control Agency monitors adverse reactions reported with Lariam and evaluates potential safety issues in the light of any new evidence that emerges. The MCA received 956 reports of 2,678 suspected adverse reactions associated with Lariam between 1990, when the product was launched in the United Kingdom, and 1 June 1996. During this time in excess of half a million patients have received Lariam. The reports received are consistent with the known safety profile of Lariam as described in the authorised product information.